Age, race/ethnicity, and comorbidities predict statin adherence after ischemic stroke or myocardial infarction

Eur J Prev Cardiol. 2020 Dec;27(19):2299-2301. doi: 10.1177/2047487319861219. Epub 2019 Jul 11.

Authors

Sheila L Chan¹, Nancy J Edwards¹, Carol Conell², Xiushui Ren³, Nader M Banki³, Vivek A Rao¹, Alexander C Flint^{1

2}

Affiliations

¹ Department of Neuroscience, Kaiser Permanente, USA.
² Division of Research, Kaiser Permanente Northern California, USA.
³ Department of Cardiology, Kaiser Permanente, USA.

PMID: 31291774
DOI: 10.1177/2047487319861219

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Age Factors
Aged
Aged, 80 and over
Comorbidity
Female
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors / administration & dosage*
Ischemic Stroke / ethnology*
Ischemic Stroke / prevention & control*
Male
Medication Adherence*
Middle Aged
Myocardial Infarction / ethnology*
Myocardial Infarction / prevention & control*
Risk Factors
Secondary Prevention*

Substances

Hydroxymethylglutaryl-CoA Reductase Inhibitors